ATA-105
N/A
Report date: 2022/11/07 19:32:29
NME
Base Information
Drug NameATA-105
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAttenua Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A